Gabelli Funds »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Gabelli Funds

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Gabelli Funds from 13F filings

Historical chart of Gabelli Funds investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Gabelli Funds consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Gabelli Funds

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.3M 3.6M 1.19
2024-06-30 $8.7M 7.9M 1.10
2024-03-31 $7.7M 7.9M 0.98
2023-12-31 $7.5M 8.0M 0.93
2023-09-30 $5.7M 6.1M 0.94

More positions owned by Gabelli Funds

Microsoft Corp Equity (MSFT)
Lennar Corp - B Equity (LEN.B)
Mastercard Inc - A Equity (MA)
Nextera Energy Equity (NEE)
American Express Equity (AXP)
Ametek Equity (AME)
Nvidia Corp Equity (NVDA)
Newmont Corp Equity (NEM)
National Fuel Gas Equity (NFG)
Kkr & Co Equity (KKR)
Gatx Corp Equity (GATX)
Republic Services Equity (RSG)
Crane Equity (CR)
Mueller Industries Equity (MLI)
Sony Group Corp - Sp Depository Recei (SONY)

View all positions for Gabelli Funds

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1